Why is Fischer Medical falling/rising?

As of 08-Oct, Fischer Medical Ventures Ltd is experiencing a decline in its stock price, currently at Rs 96.65, which reflects a decrease of Rs 4.45 or 4.4%. The stock has been underperforming, having lost 13.01% over the last five days, and it has consistently fallen for five consecutive days. In terms of performance against benchmarks, the stock has shown a significant decline of 10.51% over the past week and 14.67% over the past month, while it has outperformed the BSE500 over the longer term with a 48.41% return in the last year. Despite these recent challenges, the company has demonstrated strong fundamentals, including a low debt-to-equity ratio and impressive growth in net sales, which increased by 247.89% in the latest six months.
Broader Market Context: The broader market, represented by the Sensex, has shown a positive return of 0.98% over the past week and 1.22% over the past month, contrasting sharply with Fischer Medical's recent performance. This underperformance relative to the benchmark indicates that the stock is not only facing internal challenges but is also lagging behind the overall market trend. The rising investor participation, indicated by an 18.2% increase in delivery volume, suggests some level of interest, but the stock's current trajectory reflects a struggle to maintain momentum amidst broader market gains.